KIRREL2

KIRREL2 (NEPH3/filtrin) is an immunoglobulin-superfamily type I transmembrane cell-adhesion molecule with five extracellular Ig domains that functions at specialized cell-cell junctions in epithelia and in neural circuit assembly (PMID:12837264). In the kidney it localizes to the slit diaphragm of podocyte foot processes, where it engages in homophilic and heterophilic trans-interactions with nephrin and Neph1 to mediate cell-cell adhesion, and its trans-engagement with nephrin down-regulates nephrin tyrosine phosphorylation, linking contact formation to signaling at the filtration barrier (PMID:17442742, PMID:19887377, PMID:21306299). Its expression is controlled by a convergent transcriptional program: Ptf1a binds the 5'-flanking region to directly activate transcription, NF-κB and Sp1 drive basal promoter activity, WT1 synergizes with NF-κB, and DNA methylation silences the gene in a stage- and cell-type-dependent manner (PMID:19887377, PMID:19703278, PMID:21980157). Beyond the kidney, KIRREL2 is a direct Ptf1a target that marks cerebellar GABAergic ventricular-zone progenitors and is required for region-specific coalescence of olfactory sensory neuron axons into glomeruli in the DII domain of the olfactory bulb, with loss of function producing ectopic glomerular targeting (PMID:20004188, PMID:31142543). A V353M variant that disrupts both homo- and heterodimerization and perturbs the unfolded protein response connects its adhesive function to podocyte disease (PMID:28334007).

1. 2003 Medium

   Establishing the molecular identity of KIRREL2 was the first step: it was unknown what kind of protein it was, and structural characterization placed it as a nephrin/NEPH1-related Ig-superfamily adhesion molecule expressed in pancreatic beta cells and nervous system.

   Evidence Computational gene discovery with RT-PCR, Northern blot and immunohistochemistry

   PMID:12837264

   Open questions at the time

   • Did not establish binding partners or function
   • Tissue expression survey only, no mechanism
2. 2003 Medium

   Localizing the protein answered where it acts: immunolocalization placed filtrin at the glomerular slit diaphragm, implicating it as a component of the filtration barrier.

   Evidence RT-PCR, immunoblotting and immunofluorescence in human and rat glomeruli

   PMID:12504092

   Open questions at the time

   • Light-level localization only; ultrastructural placement not yet shown
   • Functional contribution to filtration untested
3. 2006 Medium

   Whether KIRREL2 acts only at the slit diaphragm was addressed by showing it is also expressed in pancreatic islet beta cells, extending its association to a second specialized epithelial structure.

   Evidence RT-PCR, immunoblotting and immunofluorescence in pancreatic Langerhans islets

   PMID:16841182

   Open questions at the time

   • Functional role in islets not determined
   • No partner or signaling data in beta cells
4. 2007 Medium

   Ultrastructural localization and disease correlation refined the role: immunoelectron microscopy confirmed slit-diaphragm placement and showed down-regulation in human proteinuric disease, linking KIRREL2 to barrier integrity.

   Evidence Quantitative RT-PCR, immunofluorescence and immunoelectron microscopy in normal and FSGS human glomeruli

   PMID:17442742

   Open questions at the time

   • Correlation not causation in human disease
   • Mechanism of down-regulation unknown
5. 2009 High

   How KIRREL2 expression is controlled and what it binds were answered together: Ptf1a directly activates the gene via a promoter motif, and KIRREL2 interacts homo- and heterophilically with nephrin, establishing both an upstream regulator and a physical adhesion partner.

   Evidence ChIP, promoter reporter assays, Ptf1a-null mice, ectopic expression, and co-immunoprecipitation

   PMID:19887377

   Open questions at the time

   • Functional consequence of nephrin interaction not yet defined
   • Other transcriptional inputs not assessed
6. 2009 High

   The neural role was identified: lineage tracing showed KIRREL2 is a direct Ptf1a target marking cerebellar GABAergic ventricular-zone progenitors, distinguishing Purkinje cell from interneuron progenitor pools by E-cadherin level.

   Evidence FACS, in vitro fate assays and in vivo lineage tracing with Neph3 promoter-GFP transgenic mice

   PMID:20004188

   Open questions at the time

   • KIRREL2 used as marker; its functional requirement in cerebellar fate not tested
   • Adhesive mechanism in progenitors unaddressed
7. 2009 High

   The basal transcriptional machinery was defined: NF-κB and Sp1 bind the proximal promoter and are essential for basal activity in podocytes, identifying the core regulators of constitutive expression.

   Evidence Promoter reporter constructs, site-directed mutagenesis, ChIP and co-transfection in cultured human podocytes

   PMID:19703278

   Open questions at the time

   • Signal inputs controlling these factors not defined
   • Cell-type specificity of regulation not explained
8. 2011 High

   The mechanistic role of the interactions was established: KIRREL2 homo- and heterodimerizes with nephrin and Neph1, can drive adhesion autonomously in fibroblasts, and its trans-engagement of nephrin down-regulates nephrin tyrosine phosphorylation, coupling adhesion to signaling.

   Evidence Co-immunoprecipitation, L fibroblast adhesion assay and tyrosine phosphorylation analysis

   PMID:21306299

   Open questions at the time

   • Phosphatase/kinase mediating dephosphorylation not identified
   • In vivo relevance of phosphorylation control not demonstrated
9. 2011 High

   Transcriptional control was integrated: WT1 synergizes with NF-κB, TNF-α induces expression via NF-κB, and DNA methylation silences the gene, showing combinatorial and epigenetic regulation.

   Evidence Reporter assays, ChIP, co-IP, TNF-α treatment with pathway inhibitor, and 5-aza-2'-deoxycytidine demethylation with qPCR

   PMID:21980157

   Open questions at the time

   • Physiological trigger for methylation changes not defined
   • Interplay with Ptf1a not reconciled
10. 2011 Medium

    In vivo requirement was tested: morpholino knockdown of neph3 in zebrafish produced glomerular and neural defects rescued by wild-type mRNA, providing loss-of-function evidence for a developmental role.

    Evidence Antisense morpholino knockdown in zebrafish with histology and mRNA rescue

    PMID:22099175

    Open questions at the time

    • Morpholino specificity caveats
    • Cellular mechanism behind phenotypes not resolved
11. 2017 Medium

    A disease-linked variant connected dimerization to pathology: V353M disrupts homo- and heterodimerization and alters the unfolded protein response, mechanistically linking impaired KIRREL2 interactions to podocyte dysfunction.

    Evidence Functional dimerization and UPR assays in cultured podocytes with genetic association

    PMID:28334007

    Open questions at the time

    • Causality in patient kidney disease not established
    • Single variant in cell-culture overexpression
12. 2019 High

    A definitive in vivo neural function was shown: Kirrel2 knockout mice display ectopic glomerular targeting of specific olfactory sensory neuron populations in the DII region, establishing a region-specific role in axon coalescence.

    Evidence Kirrel2 single and Kirrel2/Kirrel3 double knockout mice with analysis of defined OSN axon projections

    PMID:31142543

    Open questions at the time

    • Molecular partners of KIRREL2 in OSN axons not identified
    • Mechanism of regional specificity unexplained

• It remains unknown how KIRREL2's adhesion and signaling functions are mechanistically deployed across its different tissues, including its functional role in pancreatic beta cells and the downstream effectors linking trans-adhesion to nephrin dephosphorylation in vivo.
• No identified phosphatase mediating nephrin dephosphorylation
• Beta-cell function uncharacterized
• Cytoplasmic effectors of KIRREL2 signaling not defined